LISA TRAIL: Open Payments
NPI 1174751671 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,815 in 152 payments from 18 companies in 2025. Trend: 2023 $1,098 · 2024 $2,130 · 2025 $2,815
Food & beverage: $2,815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $697 |
| Janssen Biotech, Inc. | 13 | $292 |
| Madrigal Pharmaceuticals | 9 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $268 |
| Braintree Laboratories, Inc. | 24 | $230 |
| GENZYME CORPORATION | 6 | $205 |
| Aimmune Therapeutics, Inc. | 13 | $204 |
| Regeneron Healthcare Solutions, Inc. | 8 | $140 |
| Phathom Pharmaceuticals, Inc. | 6 | $96 |
| QOL Medical, LLC | 3 | $75 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, SUFLAVE, ENTYVIO, RINVOQ, ZENPEP, CREON.
Industry payments across TN — which companies pay providers there.
